Authors:
BOGDANOVIC G
PRIFTAKIS P
HAMMARIN AL
SODERSTROM M
SAMUELSON A
LEWENSOHNFUCHS I
DALIANIS T
Citation: G. Bogdanovic et al., DETECTION OF JC VIRUS IN CEREBROSPINAL-FLUID (CSF) SAMPLES FROM PATIENTS WITH PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY BUT NOT IN CSF SAMPLES FROM PATIENTS WITH HERPES-SIMPLEX ENCEPHALITIS, ENTEROVIRAL MENINGITIS, OR MULTIPLE-SCLEROSIS, Journal of clinical microbiology, 36(4), 1998, pp. 1137-1138
Authors:
AFGEIJERSSTAM V
WANG ZH
LEWENSOHNFUCHS I
EKLUND C
SCHILLER JT
FORSGREN M
DILLNER J
Citation: V. Afgeijersstam et al., TRENDS IN SEROPREVALENCE OF HUMAN-PAPILLOMAVIRUS TYPE-16 AMONG PREGNANT-WOMEN IN STOCKHOLM, SWEDEN, DURING 1969-1989, International journal of cancer, 76(3), 1998, pp. 341-344
Authors:
MUNCKWIKLAND E
BLEGEN H
LEWENSOHNFUCHS I
MALEC M
AUER G
KUYLENSTIERNA R
DALIANIS T
WIMAN KG
LINDHOLM J
Citation: E. Munckwikland et al., P53 OVEREXPRESSION IN NORMAL AND DYSPLASTIC TISSUES ADJACENT TO P53 NEGATIVE SQUAMOUS-CELL CARCINOMAS OF THE HEAD AND NECK, International journal of oncology, 11(1), 1997, pp. 97-104
Authors:
LEWENSOHNFUCHS I
LJUNGMAN P
KJERRSTROM A
RINGDEN O
DALIANIS T
Citation: I. Lewensohnfuchs et al., LOSS OF SEROREACTIVITY AGAINST HUMAN PAPILLOMAVIRUS (HPV) IN BONE-MARROW TRANSPLANT RECIPIENTS, Bone marrow transplantation, 18(2), 1996, pp. 333-337
Authors:
LJUNGMAN P
LORE K
ASCHAN J
KLAESSON S
LEWENSOHNFUCHS I
LONNQVIST B
RINGDEN O
WINIARSKI J
EHRNST A
Citation: P. Ljungman et al., USE OF A SEMIQUANTITATIVE PCR FOR CYTOMEGALOVIRUS DNA AS A BASIS FOR PREEMPTIVE ANTIVIRAL THERAPY IN ALLOGENEIC BONE-MARROW TRANSPLANT PATIENTS, Bone marrow transplantation, 17(4), 1996, pp. 583-587
Authors:
MAGNUSSON KP
BERKE Z
MUNCKWIKLAND E
LEWENSOHNFUCHS I
KLEIN G
DALLIANIS T
WIMAN KG
Citation: Kp. Magnusson et al., IN FRAME DELETION OF INTRON-7 IN THE P53 GENE IN A HUMAN TONSIL TUMOR, International journal of oncology, 6(1), 1995, pp. 27-29
Authors:
QUARNER H
GRUTZMEIER S
LEWENSOHNFUCHS I
HEJDEMAN B
SANDSTROM E
EHRNST A
Citation: H. Quarner et al., CMV PCR IN LEUKOCYTES AS AN EARLY MARKER FOR THE DEVELOPMENT OF CMV DISEASE IN AIDS PATIENTS, Scandinavian journal of infectious diseases, 1995, pp. 94-95
Authors:
LEWENSOHNFUCHS I
BERKE Z
WESTER D
DALIANIS T
ELFGREN K
Citation: I. Lewensohnfuchs et al., HUMAN PAPILLOMAVIRUS (HPV) DNA IS NOT DETECTED IN THE PERIPHERAL-BLOOD CELLS OF PATIENTS WITH CERVICAL-CARCINOMA, Genitourinary medicine, 70(5), 1994, pp. 359-360
Authors:
LEWENSOHNFUCHS I
MUNCKWIKLAND E
BERKE Z
MAGNUSSON KP
PALLESEN G
AUER G
LINDHOLM J
LINDE A
ABERG B
RUBIO C
KUYLENSTIERNA R
WIMAN KG
DALIANIS T
Citation: I. Lewensohnfuchs et al., INVOLVEMENT OF ABERRANT P53 EXPRESSION AND HUMAN PAPILLOMAVIRUS IN CARCINOMA OF THE HEAD, NECK AND ESOPHAGUS, Anticancer research, 14(3B), 1994, pp. 1281-1285
Authors:
LJUNGMAN P
LEWENSOHNFUCHS I
HAMMARSTROM V
ASCHAN J
BRANDT L
BOLME P
LONNQVIST B
JOHANSSON N
RINGDEN O
GAHRTON G
Citation: P. Ljungman et al., LONG-TERM IMMUNITY TO MEASLES, MUMPS, AND RUBELLA AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, Blood, 84(2), 1994, pp. 657-663
Authors:
LEWENSOHNFUCHS I
WESTER D
BISTOLETTI P
ELFGREN K
OHLMAN S
DILLNER J
DALIANIS T
Citation: I. Lewensohnfuchs et al., SEROLOGICAL RESPONSES TO HUMAN PAPILLOMAVIRUS TYPE-16 ANTIGENS IN WOMEN BEFORE AND AFTER RENAL-TRANSPLANTATION, Journal of medical virology, 40(3), 1993, pp. 188-192